WebWhat is Multaq? Multaq (dronedarone) is prescribed in people who have a history of paroxysmal or persistent atrial fibrillation but are now in good condition. Multaq belongs to the class III of antiarrhythmic drugs that helps keep a normal heartbeat rhythm to lower the chance of getting to the hospital for having atrial fibrillation again. Dronedarone, sold under the brand name Multaq, is a medication by Sanofi-Aventis, mainly for the indication of cardiac arrhythmias. It was approved by the FDA on July 2, 2009. It was recommended as an alternative to amiodarone for the treatment of atrial fibrillation and atrial flutter in people whose hearts have … Vedeți mai multe Dronedarone has been termed a "multichannel blocker". However, it is unclear which channel(s) play a pivotal role in its success. Thus, dronedarone's actions at the cellular level are controversial, … Vedeți mai multe Chemically, dronedarone is a benzofuran derivative related to amiodarone, a popular antiarrhythmic. The use of amiodarone is limited by toxicity due its high iodine content (pulmonary fibrosis, thyroid disease) as well as by liver disease. In dronedarone, the iodine … Vedeți mai multe Clinical trials have compared dronedarone to placebo and to amiodarone, for its ability to reduce atrial fibrillation, to reduce mortality overall and from cardiac causes, and for its adverse effects, including excess mortality. Dronedarone is a non-iodinated Vedeți mai multe Originally submitted as a New Drug Application in 2005, dronedarone was reviewed and recommended for approval on March 18, 2009, by an Advisory Committee … Vedeți mai multe Dronedarone is less lipophilic than amiodarone, has a much smaller volume of distribution, and has an elimination half-life of 13–19 hours—this stands in contrast to … Vedeți mai multe • Permanent AF (patients in whom normal sinus rhythm will not or cannot be restored) • Recently decompensated heart failure requiring hospitalization or Class IV heart failure. • Second-or third-degree AV block or sick sinus syndrome (except when used … Vedeți mai multe A follow on drug, poyendarone, has been developed by modifying the Dronedarone molecule to remove its tendency to cause ventricular arrhythmia. The new drug was developed by the National University of Singapore (NUS) Department of Pharmacy … Vedeți mai multe

Multaq: Uses, Dosage, Side Effects - Drugs.com

Web1 apr. 2024 · Description and Brand Names Drug information provided by: IBM Micromedex US Brand Name Cardizem Cardizem CD Cardizem LA Cartia XT Dilacor XR Dilt-CD … gsjbw superannuation fund

Is There a Safe Generic Alternative to Multaq?

WebMULTAQ is a recommended 1st-line treatment option for sinus rhythm maintenance by AHA/ACC/HRS and ESC. Learn about the guidelines for managing patients with AFib. ... NOTE: Amiodarone should only be used after consideration of risks and when other agents have failed or are contraindicated due to its potential toxicities (Class 1C). WebMultaq (dronedarone) is used to help manage atrial fibrillation and helps keep your heart beating regularly. Check out our savings tips and your potential eligibility for the … WebMultaq (dronedarone) is an antiarrhythmic. It works by blocking potassium channels, which play a major part in your heart's electrical activity. Multaq (dronedarone) slows down … finance careers in healthcare